Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 11Stomach Neoplasms 8Esophageal Neoplasms 8Colorectal Neoplasms 8Recurrence 7Rectal Neoplasms 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Sarcoma 6Uterine Cervical Neoplasms 5Pancreatic Neoplasms 5Glioma 4Endometrial Neoplasms 4Colonic Neoplasms 4Thyroid Neoplasms 3Pituitary Neoplasms 3Pilonidal Sinus 3Neoplasms 3Glioblastoma 3Cholangiocarcinoma 3COVID-19 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Pain, Postoperative 2Neoplasm Metastasis 2Melanoma 2Lymphatic Metastasis 2Kidney Neoplasms 2Inflammation 2

Interventions

Adrenalectomy 2Surgical Procedures, Operative 1Staining and Labeling 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Molecular Diagnostic Techniques 1Immunotherapy 1Genetic Testing 1Drug Therapy 1Catecholamines 1Blood Specimen Collection 1Biological Therapy 13-fluorobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pheochromocytoma × Surgical Procedures, Operative × Clear all
NCT01348698 2018-11-26

Evaluation of Molecular Markers in Adrenal Tumors

National Institutes of Health Clinical Center (CC)

Terminated
74 enrolled 10 charts
Endocrine

Adrenal Gland Neoplasms, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡